Benzodiazepines were the first-line choice of AEDs in 61% of patients, including 25% of those whose index seizure was status epilepticus. Levetiracetam was the first-line choice in another 24% of patients who had no history of seizures.
“This study provides preliminary data that could be used to plan a randomized controlled trial,” the investigators added. “Seizure recurrence was common enough that it could be a primary outcome measure.”
—Mary Ann Moon
IMNG Medical News